after completion of numerous pharmacological tests giving evidence of antidysrhythmic effects of the molecule and more especially in the digitalic arrhythmias and ventricular fibrillation induced by calcium ( where it is more active than other products tested ) , the authors conclude that cetiedil might enter in group i of vaughan and william 's classification of antiarrhythmic drugs .
C0003811
arrhythmias
C0042510
ventricular